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Objectives: To determine factors associated with diagnostic yield of ENB.
Methods: In 112 consecutive patients referred to our department between March 2010 and
December 2010 the diagnostic work-up for solitary pulmonary lesions included a FDG-PET-CT
scan, and ENB in combination with ROSE. The final diagnosis was confirmed by histopatholog-
ical evaluation of specimen obtained either by ENB, or e if ENB was not diagnostic e by CT-
guided fine needle aspiration or surgery.
Results: Thirty-seven (33%) subjects were female, mean age was 66.7 (1.04) years. The mean
diameter of lesions was 27 mm (range: 6e46 mm). In 83.9% the combination of PET-CT, ENB,
and ROSE established a correct diagnosis, as defined by the definite histopathological result.
15.2% (17/112) of lesions were benign, and 84.8% (95/112) were malignant. For 112 procedures
we observed a steep learning curve with a diagnostic yield of 80% and 87.5% for the first 30 and
last 30 procedures, respectively. The diagnostic yield in lesions 20 mm and >20 mm in diam-
eter was 75.6% and 89.6% (pZ 0.06), respectively. No significant difference in diagnostic yield
was seen depending on lung function, and the localization of the lesions. Two cases (1.8%) of
pneumothorax were seen during and up to 24 h after bronchoscopy, none of them required
a chest tube.
Conclusion: Diagnostic yield increased with experience but was independent from the size of
the lesion, the localisation in the lungs, and lung function. The diagnostic yield of ENB can be
as high as for CT-guided transthoracic biopsies but carries a significantly lower complication
rate.
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pulmonary lesions. All presented with lesions usually diffi-Data from the National Lung Screening Trial1 suggest a 20%
reduction in lung cancer mortality (and a 7% reduction in
all-cause mortality) when low-dose CT instead of chest-x-
ray is used for lung cancer screening. However, the inci-
dence of solitary pulmonary lesions increases with utiliza-
tion of more sensitive diagnostic methods. In high-risk
populations, screening for lung cancer with low-dose CT has
shown an incidence of suspicious lung nodules of 2.2%.2
Thus the clinical management of pulmonary nodules will
gain much greater attention in the near future.
Sensitivity of conventional bronchoscopy for the diag-
nosis of peripheral lung lesions <2 cm and >2 cm was re-
ported to be about 33% and 62%, respectively.3 For lesions
with a diameter of less than 2 cm located in the periphery
of the lung, the diagnostic yield decreases to 14%.4 Fluo-
roscopic guidance, endobronchial ultrasound (EBUS) or
electromagnetic navigation bronchoscopy (ENB) can help to
improve sensitivity. In peripheral lung lesions electromag-
netic navigation bronchoscopy has been shown to increase
diagnostic yield up to the range of 59e74%.5e10
Inadequate specimen collection is another factor limi-
tating the yield of bronchoscopy. For transbronchial needle
aspirates (TBNA), rapid on-site examination has been re-
ported to be highly useful, accurate and cost-effective.11 In
non-small cell lung cancer the maximum standardized
uptake value (SUV) of pulmonary nodules on positron-
emission tomography has shown to be a predictor of stage
and tumor characteristics.12 Therefore the use of PET/CT in
the diagnostic approach to peripheral lung lesions helps to
plan diagnostic (and therapeutic) procedures.
In this prospective, single-center study PET/CT was
performed prior to ENB and ROSE was used to overcome the
limitation of inadequate specimen collection. We hypoth-
esized that this combined approach to pulmonary lesions
can exceed previously reported diagnostic yield of ENB. By
now this is the largest series of patients undergoing ENB in
combination with adjunct ROSE and preceding PET-CT.
Methods
This is a single-center, prospective, observational study to
evaluate the diagnostic yield of ENB in combination with
PET/CT and ROSE and to determine factors associated with
diagnostic yield.
Clinical setting
The data were recorded at the Department of Pulmonary
Medicine, Paracelsus Medical University, Salzburg, Austria.
This is a tertiary care unit performing more than 600 bron-
choscopies per year. The majority of these procedures are
performed in subjects referred for suspected lung cancer. In
our clinical setting rapid on-site cytopathologic examination
(ROSE) andPET-CTarepart of the routinediagnosticwork-up.
Study population
One hundred and twelve consecutive patients were enrolled
between March 2010 and December 2010. All subjects werecandidates for nonemergency bronchoscopy of a solitary
cult to reach by conventional bronchoscopy: located in the
peripheral third of the chest, endobronchially invisible,
and/or too small to be visible on chest radiograph or fluo-
roscopy. The work has been approved by the ethical
committee and all subjects provided informed consent.
FDG-PET-CT
Prior to electromagnetic navigation bronchoscopy subjects
had an integrated fluorodeoxyglucose-positron-emission-
computed tomography (FDG-PET-CT). The CT scans of the
chest were configured with slices of 1 mm thickness at 0.8
mm intervals. For each patient the maximum standard
uptake value (maxSUV) of the lesion was recorded. A SUV
3 was assumed to be suggestive for malignancy.
Electromagnetic navigation bronchoscopy
PET-CT data were used to generate a three-dimensional CT
roadmap by the inReach system version 5.3 (super-
Dimension). The software version used did not have the
automatic registration or airway synchronization modalities
and worked with four viewing panes during the navigation
procedure.
The electromagnetic navigation system is an image-
guided localization device that assists the endobronchial
accessories (forceps, needle, and brush) in reaching the
endobronchially invisible peripheral lung lesions. Details of
the equipment and configuration have already been
described.13,14 All procedures were done in rigid broncho-
scopic intubation technique and general anesthesia using
an Olympus 1T160, 2.8 mm working channel, adult thera-
peutic bronchoscope. No additional guidance technique
(e.g. fluoroscopic guidance) was used. Navigation to the
lesion was assumed successful when the distance from the
tip of the locatable guide to the center of the lesion was
10 mm. Three bronchoscopists at the same level of
bronchoscopy training started to use ENB and performed
the studied 112 procedures (30e40 procedures each).
Rapid on-site cytopathologic evaluation (ROSE)
Bronchoscopy was done in combination with rapid on-site
cytopathologic examination which is routinely available at
our institution. ROSE is facilitated by immediate smearing
of the specimens onto slides, drying and fixation. An
experienced cytopathologist evaluated specimens sampled
by variable biopsy techniques (forceps biopsy with imprint
cytology, TBNA and brush with smears). The Papanicolaou
(Pap) test grading system (IeV) was used to describe find-
ings of the cytopathologic examination. For confirmation of
final diagnosis a histopathological examination was per-
formed in all cases, further immuno-histological evaluation
was performed if appropriate.
Statistical analysis
The parametric t-test was used to evaluate the impact of
lesion size on the diagnostic yield of electromagnetic
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with SAS 8.2 (SAS Institute Inc, Cary, NC, USA).
Results
Electromagnetic navigation bronchoscopy was performed in
112 patients. 37 (33%) were female, the mean age was 66.7
(range: 32e87) years. 66% (74/112) of subjects presented
with impaired lung function (FEV1< 80% predicted), the
mean FEV1% predicted was 69% (range: 26e144%). Charac-
teristics of pulmonary lesions are summarized in Table 1.
The mean Standard Uptake Value (SUV) recorded by PET-
CTwas 6.7, and was significantly higher in malignant lesions
than in benign lesions (7.4 vs 2.9, p< 0.001). The positive
predictive value of a suspicious PET-CT scan for a diagnosis
of malignancy was 93.3%.
All bronchoscopic procedures were done in general
anesthesia. Mean duration of general anesthesia including
total bronchoscopic procedure time was 45.0 (2.0) and
45.4 (2.8) minutes for lesions >20 mm and lesions
20 mm in diameter, respectively.
A flow diagram of the diagnostic work-up of pulmonary
lesions is shown in Fig. 1. Overall, in 83.9% the combination
of PET-CT, ENB, and ROSE established a correct diagnosis,
as defined by the definite histopathological result. 15.2%Table 1 Characteristics of solitary pulmonary lesions
(nZ 112).
Size (mm)
Mean 27.1 (1.3)
Median 25.0
Range 6e46
Localization
Right lung 69 (61.6%)
Left lung 43 (38.4%)
Upper lobe 57 (50.9%)
Lower lobe 41 (36.6%)
Middle lobe 14 (12.5%)
Dignity & final diagnosis
Malignant lesions 95 (84.8%)
NSCLC 81 (72.3%)
BALT lymphoma 1 (0.9%)
Metastases 13 (11.6%)
Benign lesions 17 (15.2%)
Tuberculoma 4 (3.6%)
Hamartoma 2 (1.8%)
Vasculitic granuloma
(Polyarteriitis nodosa)
1 (0.9%)
Eosinophilic granuloma 2 (1.8%)
Epitheloid granuloma (Sarcoidosis) 2 (1.8%)
Mycetoma 3 (2.7%)
Necrotizing granuloma
(Rheumatoid arthritis)
1 (0.9%)
Organizing pneumonia 2 (1.8%)(17/112) of lesions were benign, and 84.8% (95/112) were
malignant. The number of biopsies taken to establish the
diagnosis ranged from 1 to 9 (median of 6 biopsies).
The diagnostic yield of ENB in lesions 20 mm and
>20 mm in diameter was 75.6% and 89.6%, respectively
(pZ 0.06). No significant difference in diagnostic yield was
seen depending on the localization e lower lobes vs upper
lobes e of the lesions, see Table 2.
The diagnostic yield of ENB was found to be independent
from lung function (FEV1% predicted). Among 38 subjects
with normal lung function (FEV1 80% predicted) the
diagnostic yield was 78.9% (30/38), among 30 subjects with
severe to very severe airways obstruction (FEV1 50%
predicted) the diagnostic yield was 93.3% (28/30). The
mean FEV1% predicted was 67.7% and 75.6% for subjects
with reachable and unreachable pulmonary lesions,
respectively (pZ 0.127).
Diagnostic yield of ENB increased with the number of
performed procedures. For the observed 112 ENB proce-
dures, the average diagnostic yield was 80% and 87.5%
(pZ 0.724) for the first 30 and the last 30 procedures,
respectively (see Fig. 2). In parallel to this increasing
diagnostic yield the mean diameter of lesions decreased
from 30.4 mm to 25.3 mm.
When navigation to the lesion was successful (distance
from the tip of the locatable guide to the center of the
lesion 10 mm), sensitivity and specificity of rapid on-site
cytopathologic examination (ROSE) for a diagnosis of
malignancy was 92.6% and 100%, respectively.
In 11 cases (9.8%) navigation was not successful (distance
from the tip of the locatable guide to the center of the
lesion >10 mm), in 7 (6.2%) cases navigation seemed to be
successful but collected specimen/ROSE were not diag-
nostic. Altogether, in 16% (18/112) the combined procedure
(PET-CT, ENBþ ROSE) did not allow to establish a diagnosis.
These cases were subsequently diagnosed by surgery
(nZ 10) or by CT-guided fine needle aspiration (nZ 8).
Two cases (1.8%) of pneumothorax were seen during and
up to 24 h after bronchoscopy, none of them required
a chest tube. No other adverse events were seen.Discussion
In this series of 112 consecutive patients with solitary
pulmonary lesions the combination of PET-CT, electro-
magnetic navigation bronchoscopy, and rapid on-site cyto-
pathologic examination established a diagnosis in 84%.
This is significantly better than the diagnostic yield of
53% that was shown for the combination of flexible stan-
dard bronchoscopy with the use of uniplanar fluoroscopy
and PET scanning (in lesions less than 3 cm in size).15 It has
been shown that ENB is a safe procedure and can increase
the diagnostic yield of bronchoscopy up to approximately
70%.6e9,16 In the presence of a bronchus sign on CT imaging
ENB has recently been shown to be diagnostic in 79%.17 The
diagnostic yield observed in our large series of patients is
even higher and close to the diagnostic yield that is re-
ported for transthoracic CT-guided (92%)3 or surgical
(nearly 100%)18 biopsies. In contrast to these more invasive
procedures with several risks,19,20 bronchoscopy has less
risks and is usually more comfortable.21
Figure 1 Flow diagram of diagnostic work-up.In subjects in shaded boxes (n Z 94) the combination of PET-CT, ENB, and ROSE
established a correct diagnosis, as defined by the definite histopathological result.
) PET-CT and ENB þ ROSE provided concordant results.
y PET-CT was not suggestive for a malignant process, but specimen obtained by ENB confirmed malignancy.
z PET-CT was suggestive for a malignant process, but specimen obtained by ENB confirmed a benign inflammatory process.
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thorax were seen during and up to 24 h after bronchoscopy.
Previous studies on ENB reported an incidence of pneumo-
thorax between none and 8%.6e9 This is remarkably lower
than the pneumothorax rate reported for CT-guided coaxial
cutting needle biopsies (23%).19 A recent study on 102 cases
of CT-guided tru-cut thransthoracic biopsies (TTB) revealed
a rate of pneumothorax of 15.7%, more than half of them
(8.8%) required a chest tube.22 When lesion size was less
than 2 cm or emphysematous changes were present the rate
of pneumothorax increased up to 30% and 28%, respectively.
The issue of this complication is highly important, since
the majority of subjects with pulmonary lesions presents
with impaired lung function e in our study the mean FEV1%
predicted was 69%.
Besides the greater risk of pneumothorax and bleeding,
transthoracic needle biopsy using intermittent CT-guidanceTable 2 Diagnostic yield (nZ 112).
Overall 83.9% (94/112)
Size
20 mm 75.6% (34/45) pZ 0.066
>20 mm 89.6% (60/67)
Localization
Right lung 85.5% (59/69) pZ 0.603
Left lung 81.4% (35/43)
Upper lobe 84.2% (48/57) pZ 1
Lower lobe 82.9% (34/41)also causes additional radiation exposure for both, the
patient and the operator.
We observed a very satisfactory diagnostic yield right
from the beginning. The diagnostic yield increased on
average from 80% to 87.5% after about 30e40 ENB proce-
dures for each bronchoscopist. Even though inclusion
criteria remained unchanged, the average diameter of the
lesions slightly decreased over time. We observed a trend
towards referral of smaller lesions and we suppose this is
due to both, increasing lung cancer screening efforts and
increasing awareness (among our referring physicians) that
innovative and promising bronchoscopy tools are available
(at our institution).
Advantages of the combined approach to
pulmonary lesions
ENB uses anatomical data and CT scans convertible into
multiplanar images with three-dimensional virtual bron-
choscopy reconstruction. In addition to this PET-CT
provides information on tissue activity and is a discrimi-
nator of disease load.23 There is evidence that the
maximum standard uptake value (maxSuv) on PET-CT is an
independent predictor of stage and tumor characteristics in
non-small lung cancer. The integrated PET-CT has been
shown to improve the diagnostic accuracy of the staging of
non-small-cell lung cancer.24 While PET-CT adds valuable
information to the staging process, it does not provide
a definite tissue diagnosis. Therefore, tissue sampling is still
required to confirm the suspected malignancy.25 For tissue
sampling rapid on-site cytopathologic examination is useful
and cost-effective. ROSE has been shown to improve
Figure 2 Diagnostic yield by number of performed ENB procedures (learning curve) for three bronchoscopists; left, individual
learning curves; right, average learning curve.
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histology of the lesion and experience of the operator.26
Previous studies have indicated that diagnostic yield can
be improved when ENB is performed in combination with
ROSE.27,28 While ENB helps to reach SPN’s, rapid on-site
cytopathologic examination ensures that the collected
specimen are diagnostic. Therefore, the combination of
ENB and ROSE helps to overcome the limitation of inade-
quate specimen collection. On the one hand, on-site
determination of cytologic adequacy helps to allow termi-
nation of the bronchoscopy to minimize the risk of potential
complications, and on the other hand, it dictates the need
for additional collection of specimen to improve the diag-
nostic yield. Especially in the latter case the use of ROSE
may slightly prolong bronchoscopy and time of anesthesia.
ENB (in combination with PET-CT and ROSE) is an
expensive procedure and has not yet established a clear
place in routine practice.29 However, there are several
indications and subsets of patients in which this procedure
appears to be a specifically reasonable work-up: (1)
a medically inoperable patient requiring tissue confirma-
tion of malignancy prior to the initiation of radiotherapy
with curative intent. (2) A patient with a pulmonary lesion
suspicious for a specific benign disease, especially if
accompanied by negative or inconclusive PET finding. (3)
And last but not least a patient preferring confirmation of
malignancy prior to the initiation of more invasive proce-
dures such as lobectomy. In our study population 24.1%
were inoperable due to severely impaired lung function
and/or significant comorbid disease. For another 10.7%
a specific benign disease was considered possible.
A limitation of this study is that it is using data from one
single-center. In addition to this, bronchoscopy in general
anesthesia is likely to improve diagnostic yield compared to
bronchoscopy in conscious sedation. Diagnostic yield was
higher in lesions >20 mm compared to lesions 20 mm, but
this difference did not reach the level of statistical signif-
icance (pZ 0.06). However, statistical significance might
have been reached in a larger cohort of patients.
Conclusions
Diagnostic yield was found independent from the size of the
lesion, the localisation in the lungs, and lung function, but
the yield increased with experience. In combination with
helpful information from PET-CT and ROSE a diagnosticyield of about 80% is within reach right from the beginning.
With increasing experience diagnostic yield of ENB can be
as high as for CT-guided transthoracic biopsies. However,
the complication rate (1.8% pneumothorax rate for ENB in
this study) is significantly lower than the one associated
with CT-guided transthoracic biopsies. In the face of an
increasing number of detected pulmonary lesions, ENB can
be a reasonable work-up in defined subsets of patients.
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